This year, the Lasker Foundation confers its Clinical Medical Research Award on Akira Endo for his isolation from fungi of statins, potent inhibitors of cholesterol synthesis in the liver. The introduction of statins to clinical practice has markedly reduced morbidity and mortality from atherosclerotic cardiovascular disease
Abstract Statins reduce cholesterol biosynthesis by inhibiting HMG-CoA reductase and thereby lower t...
Full list of author information is available at the end of the articleBackground Statins represent a...
Clinical lipidology has gained its recognition with the publication of numerous clinical trials sinc...
This year, the Lasker Foundation confers its Clinical Medical Research Award on Akira Endo for his i...
Lasker award in 2008, identified a fungal metabolite that blocked cholesterol synthesis by inhibitin...
The discovery of the statins was a great success in car-diovascular research and pharmaceuticals dev...
Statins reduce cholesterol biosynthesis by inhibiting HMG-CoA reductase and thereby lower total chol...
SummaryStatins have been shown to reduce cardiovascular events across a broad spectrum of patients a...
The introduction of statins has drastically changed the treatment and prevention of atherosclerotic ...
Statins are the main pharmaceutical agents of cholesterol-lowering therapy for years. The lipid redu...
Statins are lipid-lowering agents and one of the most pre-scribed drugs worldwide. Their main mechan...
Alberto Corsini, Nicola Ferri, Michele CortellaroDepartment of Pharmacological Sciences and Departme...
Nonalcoholic fatty liver disease (NAFLD) describes a spectrum of alcohol-like hepatic histological c...
Statins, or 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, are widely used to...
This editorial refers to ‘Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity ...
Abstract Statins reduce cholesterol biosynthesis by inhibiting HMG-CoA reductase and thereby lower t...
Full list of author information is available at the end of the articleBackground Statins represent a...
Clinical lipidology has gained its recognition with the publication of numerous clinical trials sinc...
This year, the Lasker Foundation confers its Clinical Medical Research Award on Akira Endo for his i...
Lasker award in 2008, identified a fungal metabolite that blocked cholesterol synthesis by inhibitin...
The discovery of the statins was a great success in car-diovascular research and pharmaceuticals dev...
Statins reduce cholesterol biosynthesis by inhibiting HMG-CoA reductase and thereby lower total chol...
SummaryStatins have been shown to reduce cardiovascular events across a broad spectrum of patients a...
The introduction of statins has drastically changed the treatment and prevention of atherosclerotic ...
Statins are the main pharmaceutical agents of cholesterol-lowering therapy for years. The lipid redu...
Statins are lipid-lowering agents and one of the most pre-scribed drugs worldwide. Their main mechan...
Alberto Corsini, Nicola Ferri, Michele CortellaroDepartment of Pharmacological Sciences and Departme...
Nonalcoholic fatty liver disease (NAFLD) describes a spectrum of alcohol-like hepatic histological c...
Statins, or 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, are widely used to...
This editorial refers to ‘Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity ...
Abstract Statins reduce cholesterol biosynthesis by inhibiting HMG-CoA reductase and thereby lower t...
Full list of author information is available at the end of the articleBackground Statins represent a...
Clinical lipidology has gained its recognition with the publication of numerous clinical trials sinc...
DOI
Add to ORKG